NASDAQ: NEONeogenomics Inc Stock Ownership - Who owns Neogenomics?
Insider buying vs selling
Have Neogenomics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Alicia C. Olivo | General Counsel | 2024-11-15 | 5,175 | $15.36 | $79.47kSell |
| Alicia C. Olivo | General Counsel | 2024-08-15 | 1,040 | $16.05 | $16.70kSell |
| Alicia C. Olivo | General Counsel | 2024-05-15 | 1,049 | $15.74 | $16.51kSell |
| Melody Harris | Chf Ops Off Pres Informatics | 2024-05-11 | 1,722 | $14.86 | $25.59kSell |
| Alicia C. Olivo | General Counsel | 2024-05-11 | 1,584 | $14.86 | $23.54kSell |
| Christopher M. Smith | Chief Executive Officer | 2024-05-11 | 18,913 | $14.86 | $281.05kSell |
| Warren Stone | Chief Commerical Officer | 2024-05-11 | 2,341 | $14.86 | $34.79kSell |
| Jeffrey Scott Sherman | Chief Financial Officer | 2024-05-11 | 3,167 | $14.86 | $47.06kSell |
| Lynn A. Tetrault | Director | 2024-03-04 | 6,112 | $15.97 | $97.58kSell |
| Alicia C. Olivo | General Counsel | 2024-02-15 | 2,587 | $14.96 | $38.71kSell |
NEO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NEO insiders and whales buy or sell their stock.
NEO Shareholders
What type of owners hold Neogenomics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc 1 | 15.51% | 19,911,343 | $353.03M | Institution |
| Electric Co General | 11.69% | 15,000,000 | $265.95M | Insider |
| Vanguard Group Inc | 10.94% | 14,044,094 | $249.00M | Institution |
| Peter M. Peterson | 6.39% | 8,202,050 | $145.42M | Insider |
| Steven C. Jones | 5.76% | 7,393,510 | $131.09M | Insider |
| Brown Advisory Inc | 5.37% | 6,889,145 | $122.14M | Institution |
| Janus Henderson Group PLC | 5.14% | 6,603,180 | $117.07M | Institution |
| T Rowe Price Investment Management Inc | 5.10% | 6,541,400 | $115.98M | Institution |
| State Street Corp | 3.86% | 4,958,582 | $87.92M | Institution |
| Michael T. Dent | 3.86% | 4,952,750 | $87.81M | Insider |
NEO vs Diagnostic & Research Stocks
Neogenomics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.